Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Raghu Pullakhandam has a total of 286 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Reduced Erythropoietic Signalling may be responsible for anemia without iron deficiency among Indian Pregnant Women: findings from a cross-sectional study

    by Ravindranadh Palika, Monica Chilumula, Teena Dasi, Santosh Kumar Banjara, Sai Ram Challa, Hilary Davies Kershaw, Elaine Ferguson, Bharati Kulkarni, Raghu Pullakhandam

  • Open Access

    Authors’ response

    by Ravindranadh Palika, Teena Dasi, Devraj J. Parasannanavar, Santosh Kumar Banjara, Bharati Kulkarni, Raghu Pullakhandam

  • Open Access

    Effect of household food preservation technology and nutrition education on women’s dietary intake across seasons in rural Bangladesh

    by Ankita Mondal, Nupur Nandan Nagwekar, Vaibhav Tidke, Chayan Kumer Saha, Monjurul Alam, Mamidi Raja Sriswan, Raghu Pullakhandam, Bharati Kulkarni

    Seasonal food insecurity and low dietary diversity remain persistent challenges for women in rural Bangladesh. This study assessed whether integrating a solar conduction dryer (SCD) with community-based nutrition education (NE) improves dietary diversity among women of reproductive age in subsistence farming households. A pair-matched, cluster-randomized controlled pilot trial was conducted in eight villages of Nilphamari district, Rangpur Division (n=220; 110 intervention, 110 control) over one agricultural cycle (2018-2019). Intervention households received an SCD with training on drying, safe storage, and use of preserved foods, while both arms participated in structured NE sessions.The primary outcome was minimum dietary diversity for women (MDD-W≥5), assessed using 24-hour recalls at baseline and endline during the lean season. Intention-to-treat analyses using generalized linear mixed models accounted for clustering and baseline differences. At endline, 30.9% (95% CI: 18.5-43.3) of women in the intervention arm achieved MDD-W compared with 13.1% (95% CI: 5.1-21.1) in the control arm (p=0.02). Increases in dietary diversity were accompanied by higher consumption of animal-source foods and fruits. No significant effects were observed for anthropometric or biochemical outcomes.Women dried nearly 40 food items and reported high acceptability, citing reduced spoilage and improved food availability during lean months. Integrating food preservation technology with nutrition education is feasible and may improve dietary diversity in seasonally vulnerable settings. Larger studies are needed to assess sustainability and cost-effectiveness.

  • Open Access

    Machine learning-based prediction of inflammation adjusted iron deficiency anaemia using blood cell indices

    by Ravindranadh Palika, Teena Dasi, Devraj J. Parasannanavar, Santosh Kumar Banjara, Bharati Kulkarni, Raghu Pullakhandam

    Background and objectives: Diagnosis of iron deficiency anaemia (IDA), where both anaemia and iron deficiency coexist, is essential to improve the precision of iron treatment. The serum ferritin, a marker of iron deficiency, is an acute phase protein, requires adjustment for inflammation prior to using it for diagnosis of IDA. The blood cell indices (referred as complete blood counts, CBC) help in identifying the underlying cause of anaemia and presence of inflammation, both of which could be utilised for differential diagnosis of IDA. We conducted this study to evaluate machine learning (ML) models for predicting inflammation-adjusted IDA from CBC data. Methods: We utilised CBC data from National Health and Nutrition Examination Survey (NHANES 2017-2023) of women of reproductive age (15-50 yr age, n=3604) and evaluated the performance of ML models to predict the inflammation adjusted IDA, in terms of sensitivity and specificity. We validated the performance of the optimised random forest (RF)- ML model, on women of reproductive age data set from India (n=381) in predicting the IDA, and haemoglobin response to iron treatment. Results: The optimised RF model predicted the inflammation adjusted IDA, solely based on CBC, with sensitivity and specificity of ∼95% either on the test or validation data. In those predicted to have IDA (2.3±1.6 g/dL, n=283), the haemoglobin increments due to iron therapy was markedly higher compared to those predicted to have non-IDA (0.31±0.67 g/dL, n=98). Interpretation and conclusions: These findings suggest that it is possible to predict inflammation adjusted IDA with high sensitivity and specificity with ML models using CBC data.


  • Open Access

    A Comprehensive Review of Iron Prophylaxis in the National Anemia Control Programme in India (Anemia-Mukt Bharat)

    by Subhanwita Manna, Ranadip Chowdhury, Raghu Pullakhandam, Tanica Lyngdoh, K. Madhavan Nair, Vani Kandpal, Kapil Yadav, Molly Jacob, Abhishek Jaiswal, Priyanka Gupta Bansal, et al.

    Anaemia remains a significant public health issue in India, despite five of control programs. Anaemia affects 52-67% of target populations in India despite five decades of control programmes. We conducted a review of reviews and meta-analyses (SRMAs) of regional studies to evaluate daily versus intermittent oral iron and iron-folic acid (IFA) supplementation across age groups. We identified 21 SRMAs (17 high-quality, 4 moderate-quality) and 44 regional studies from India and South Asia. IFA prophylaxis consistently improved haemoglobin levels (4.1-8.8 g/L increase) and ferritin concentrations, reducing anaemia risk by 23-70% across all age groups. IFA prophylaxis consistently improved haemoglobin levels (4.1-8.8 g/L increase) and ferritin concentrations, reducing anaemia risk by 23-70% across all age groups. Daily and intermittent regimens showed similar haematological outcomes in children, adolescents, and women of reproductive age. Among pregnant women, daily supplementation was superior for haemoglobin and ferritin levels, though intermittent dosing had fewer gastrointestinal side effects. These findings support weekly IFA supplementation for non-pregnant beneficiaries as an evidence-based strategy, even in settings where anaemia prevalence exceeds 40%. Further research on long-term safety in non-iron-deficient populations is needed.


  • Open Access

    Impact evaluation of a population-based ‘Screen and Treat for Anaemia Reduction (STAR)’ strategy: a cluster randomised trial in rural Telangana, India

    by Raghu Pullakhandam, Little Flower Augustine, Santosh Kumar Banjara, Teena Dasi, Ravindranadh Palika, Rajesh Majumder, Santu Ghosh, Anju Sinha, Bharati Kulkarni

    Introduction: Population level screen and treat approach for anaemia reduction could be beneficial but its feasibility and impact remains to be tested. Methods: This cluster randomised trial in rural Telangana included 14 clusters randomised (1:1) to either intervention or control arms. A cluster included all participants (6 months to 50 years) served by a frontline health worker. In the intervention arm, participants were screened for anaemia at point of care, using WHO 2011 cut-offs, followed by iron–folic acid (IFA) supplementation as per the national guidelines. The control arm participants were eligible for benefits of an ongoing national programme. The primary outcome was mean difference (MD) in haemoglobin between two arms at 6 months. The trial was registered at CTRI (CTRI/2019/01/016918). Results: Baseline characteristics of participants in the intervention (n=6131) and control (n=5255) arms were broadly similar. In the intervention arm, 88.6% of eligible participants were screened and intervention was delivered to 97% of participants. There was no difference in population haemoglobin (g/dL) between the arms (MD 0.03, 95% CI −0.06 to 0.12, p=0.464). However, after adjustment for relevant confounders, mean haemoglobin in the intervention arm was significantly higher (MD 0.25 g /dL, 95% CI 0.03 to 0. 48, p=0.028). Anaemia prevalence was lower in the intervention than the control arm in total sample (29.6% vs 32.5%, p=0.002) as well as in adolescent girls (40.7% vs 56.0%, p<0.001) and women of reproductive age (WRA, 52% vs 56.5%, p=0.02). Compliance to IFA (% consumption of prescribed dose) was 32% and 47.5% in those receiving therapeutic and prophylactic doses, respectively. Conclusion: This study demonstrates the feasibility of implementing a population level screen and treat approach. The intervention reduced anaemia prevalence significantly among vulnerable groups, particularly adolescent girls and WRA. Modest improvement in population haemoglobin and anaemia reduction suggests a need for strategies to improve the compliance to IFA. Trial registration number: CTRI/2019/01/016918.


  • Open Access

    PRAYAS: Cohort profile for Pooled Research and Analysis for Yielding Anemia-free Solutions in India

    by Anuj Kumar Pandey, Anju Pradhan Sinha, Ramu Rawat, Ranadip Chowdhury, Shivaprasad S Goudar, Jitender Nagpal, Shrey Desai, Avula Laxmaiah, Kalpana Basany, Sadhana Joshi, et al.

    Purpose: This cohort would aim to estimate the prevalence of anemia among children under 18 years, non-pregnant and non-lactating (NPNL) women, and pregnant women (by trimester), with further stratification by age group, year, and region of India. Cohort would also help address extended deliberation concerning etiological fraction of iron and other key erythropoietic micronutrient deficiencies contributing to anemia in India. Additionally, this will help assess the effectiveness of existing anaemia prevention and treatment interventions and examine factors associated with non-response, thereby supporting the “test–treat–track” approach. Participants: Children under 18 years, pregnant women, and non-pregnant-non-lactating women (NPNL) in India. Findings to date: This cohort profile comprises 88 datasets spanning between 1994 to 2023, encompassing a total of 319,721 participants for prevalence analysis [children(19,762), NPNL(17,883), and pregnant women(282,076)]. Additionally, 59,292 participants were included in intervention studies [children(13,435), NPNL(11,594), and pregnant women(34,263)]. RCTs comprised 55.7% (49/88) of the datasets whereas observational studies comprise 35.2% (31/88) of the datasets. Majority of the studies were from the norther region - 38 studies (43.2%), followed by the western part - 20 studies (22.7%). The southern part contributed 16 studies (18.2%). Major [59/88 (67%)] datasets in cohort were from community-based studies. The sample included NPNL and pregnant women with a median age of 26 years (IQR 23-32), and 23 years (IQR 21-25) respectively. Information from 6 months up to 18 years was pooled within the children’s cohort. Within the pregnancy cohort the mean gestational age at enrollment was 10.24 weeks(SD-17.65). Of total 10.8% (34,442/ 319,721), 9% (28,672), 4.5% (14,240) of the sample had information on complete blood count, ferritin and vitamin B12 respectively. A total of 33 datasets (sample - 59,292) were from intervention studies. Among pregnant women, a broader range of interventions was implemented, including intravenous iron sucrose, ferric carboxymaltose, iron isomaltoside, IV iron combined with vitamin B12, folic acid, and niacinamide, integrated interventions, as well as low-dose calcium supplementation. A similar set of interventions were delivered to NPNL group with being distinct which compared Ferrous sulfate tablets of 60 mg elemental iron daily with a control of 120 mg on alternate days. Ferrous sulfate was the major interventions amongst children along with food supplements and some were Ayush trials. Future plans: The PRAYAS will provide robust, high-quality evidence to inform public health policy in India. The findings will feed into the Anemia Mukt Bharat program recommendations for pregnant women, NPNL women and children to guide targeted strategies for reduction of anemia and its associated health burdens across vulnerable populations. Strengths and limitations of this study: The harmonized PRAYAS pooled Indian dataset is one of the largest, reliable and most comprehensive datasets on pregnant/ non-pregnant and non-lactating women and children. One of its kind of dataset with information on hemoglobin levels, relevant biochemical and key micronutrients parameters and varied interventions from across India. Heterogeneity of interventions, dosage, duration and data collection approaches. Studies lack critical parameters needed to assess changes in haemoglobin concentration like non-availability of key erythropoietic micronutrients in most of the studies, limiting the scope of certain analyses.

  • Zinc-Biofortified Rice Improves Growth in Zinc-Deficient Rats

    by Venu Konda, Ravindranadh Palika, Ananthan Rajendran, C. N. Neeraja, R. M. Sundaram, Raghu Pullakhandam

    Biofortification of staple food crops with zinc (Zn) is considered a sustainable strategy to prevent deficiency, but evidence on their health impact is awaited. The weaning Wistar/Kyoto male rats were fed on a Zn-deficient diet (ZDD, < 0.1 ppm) for 4 weeks followed by repletion (pair feeding) with control rice diet without (CRD; 5.0 ± 0.23 ppm) or with additional Zn (CRD + Zn, 30.3 ± 0.60 ppm) or biofortified rice diet (BRD; 8.54 ± 0.51 ppm) for 3 weeks. Body weights, plasma, liver, pancreatic, fecal Zn levels, and intestinal ZIP4 and ZnT1 mRNA expression were measured at the end of the experiment. The body weight of rats fed on CRD or CRD + Zn or BRD significantly increased (p < 0.01) compared to rats fed on ZDD. The body weight BRD was significantly higher compared to CRD (P < 0.01), both of which remained lower compared to CRD + Zn (p < 0.03). Repletion of Zn through either CRD or BRD significantly increased the plasma Zn concentration (PZC), tissue, and fecal Zn excretion compared to ZDD, without significant between-group differences. However, PZC, tissue, and fecal Zn of CRD + Zn was significantly higher compared to the rest of the groups. The intestinal ZIP4 and ZnT1 mRNA expressions are consistent with Zn status and/or dietary Zn exposure. A similar PZC, tissue, and fecal Zn in CRD compared to BRD, despite higher Zn intakes in the latter, could be due to preferential shuttling of Zn for growth. Together, these results indicate that Zn from biofortified rice is efficiently utilized for promoting the growth in Zn-deficient rats.


  • A Fluorometric Method for Zinc Estimation: Applications in the Estimation of Plasma Zinc and in Assessing Zinc Bioaccessibility from Rice

    by Puneeta Singh Yaduvanshi, Ravindranadh Palika, Raghu Pullakhandam

    Sensitive and precise methods for the estimation of zinc (Zn) in biological fluids and foods are important tools in understanding the various aspects related to Zn nutrition. Estimation of serum/plasma Zn was suggested for assessing the population Zn status while assessing the bioaccessible Zn following simulated gastrointestinal digestion of crop varieties such as rice helps in ranking the crops. Atomic absorption spectrometry (AAS) or inductively coupled plasma-mass spectrometry (ICP-MS) are widely used for Zn estimation. Zinquin, a Zn fluorophore, has been used for the localization of cellular Zn and labile Zn pools in biological fluids with extremely high sensitivity. However, it was not tested for its use in Zn estimation in serum/plasma or in assessing the Zn bioaccessibility from foods. In the current study, we demonstrate a sensitive method for Zn estimation in human plasma and validate it against the reference method (AAS) by comparing the paired measurements on the same samples. The method-related bias between zinquin with AAS was negligible (0.48 µg/dL), and the precision (CV) of the assay was < 5% across different Zn concentrations. In addition, we also demonstrated the utility of zinquin assay in estimating the bioaccessibility of Zn from rice varieties and showed that the method is again comparable to AAS. The zinquin method is capable of discriminating the differences in zinc bioaccessibility between polished and unpolished rice varieties. In the context of required low plasma volume (100 µL Vs 400 µL), excellent comparability of the results with the reference method and analytical simplicity could be particularly useful.


  • Open Access

    Eggs for Improving Nutrition, cognitive development and reducing linear growth retardation among Infants and young Children (ENRICH): protocol of an egg supplementation trial among children aged 9–18 months in Hyderabad, India

    by Santosh Kumar Banjara, Sai Ram Challa, Little Flower Augustine, Teena Dasi, Radhika Madhari, Sylvia Fernandez Rao, Ravindranadh Palika, Raghu Pullakhandam, Rajender Rao Kalashikam, Ramachandrappa Naveen Kumar, et al.

    Introduction Evidence on the impact of nutrient-rich animal source foods such as eggs for improving child growth and cognition is inconsistent. This study aims to examine the impact of an egg intervention in children, along with behaviour change communication (BCC) to the mother, on linear growth and cognition, and nutritional status in children aged 9–18 months. Methods and analysis A 9-month open-labelled randomised controlled trial will be conducted in three urban slums in Hyderabad, India, as a substudy of an observational cohort study (n=350) following pregnant women and their children until 18 months of age in a population at risk of stunting. The children born to women enrolled during the third trimester of pregnancy will be block randomised in a 1:4 ratio into the intervention (n=70) and control (n=280) groups. Children in the intervention group will be supplemented with one egg per day starting from 9 months until 18 months of age. BCC designed to enhance adherence to the intervention will be used. The control group will be a part of the observational cohort and will not receive any intervention from the study team. The primary outcome will be length-for-age z-scores, and the secondary outcomes will include cognition, blood biomarkers of nutritional status including fatty acid profile and epigenetic signatures linked with linear growth and cognition. Multivariate intention-to-treat analyses will be conducted to assess the effect of the intervention. Ethics and dissemination The study is approved by the Institutional ethics committees of ICMR-National Institute of Nutrition, Hyderabad, India and London School of Hygiene and Tropical Medicine, UK. The results will be published in peer-reviewed journals and disseminated to policy-makers. Findings will also be shared with study participants and community leaders. Trial registration number CTRI/2021/11/038208